Return On Assets of ENANTA PHARMACEUTICALS INC from 31 Dec 2013 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
ENANTA PHARMACEUTICALS INC quarterly and annual Return On Assets in % history and change rate from 31 Dec 2013 to 30 Sep 2025.
  • ENANTA PHARMACEUTICALS INC Return On Assets for the quarter ending 30 Sep 2025 was -26%, a 8.9% increase year-over-year.
  • ENANTA PHARMACEUTICALS INC annual Return On Assets for 2025 was -26%, a 8.9% increase from 2024.
  • ENANTA PHARMACEUTICALS INC annual Return On Assets for 2024 was -29%, a 13% increase from 2023.
  • ENANTA PHARMACEUTICALS INC annual Return On Assets for 2023 was -33%, a 8.3% decline from 2022.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

ENANTA PHARMACEUTICALS INC Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -26% +2.6% +8.9% 01 Jul 2025 30 Sep 2025
Q2 2025 -27% -0.19% -0.7% 01 Apr 2025 30 Jun 2025
Q1 2025 -27% +2.6% +9% 01 Jan 2025 31 Mar 2025
Q4 2024 -27% +5% +15% 01 Oct 2024 31 Dec 2024
Q3 2024 -29% +4.1% +13% 01 Jul 2024 30 Sep 2024
Q2 2024 -27% +7.1% +21% 01 Apr 2024 30 Jun 2024
Q1 2024 -29% +5.5% +16% 01 Jan 2024 31 Mar 2024
Q4 2023 -32% -0.44% -1.4% 01 Oct 2023 31 Dec 2023
Q3 2023 -33% -2.5% -8.3% 01 Jul 2023 30 Sep 2023
Q2 2023 -34% -5.5% -19% 01 Apr 2023 30 Jun 2023
Q1 2023 -35% -8.9% -34% 01 Jan 2023 31 Mar 2023
Q4 2022 -32% -9.4% -42% 01 Oct 2022 31 Dec 2022
Q3 2022 -30% -13% -76% 01 Jul 2022 30 Sep 2022
Q2 2022 -29% -11% -62% 01 Apr 2022 30 Jun 2022
Q1 2022 -26% -11% -70% 01 Jan 2022 31 Mar 2022
Q4 2021 -22% -11% -93% 01 Oct 2021 31 Dec 2021
Q3 2021 -17% -10% -140% 01 Jul 2021 30 Sep 2021
Q2 2021 -18% -18% -3906% 01 Apr 2021 30 Jun 2021
Q1 2021 -15% -20% -419% 01 Jan 2021 31 Mar 2021
Q4 2020 -12% -19% -266% 01 Oct 2020 31 Dec 2020
Q3 2020 -7.2% -17% -172% 01 Jul 2020 30 Sep 2020
Q2 2020 0.47% -14% -97% 01 Apr 2020 30 Jun 2020
Q1 2020 4.8% -13% -74% 01 Jan 2020 31 Mar 2020
Q4 2019 7% -15% -68% 01 Oct 2019 31 Dec 2019
Q3 2019 9.9% -9.5% -49% 01 Jul 2019 30 Sep 2019
Q2 2019 14% -8.8% -38% 01 Apr 2019 30 Jun 2019
Q1 2019 18% +2.1% +13% 01 Jan 2019 31 Mar 2019
Q4 2018 22% +10% +91% 01 Oct 2018 31 Dec 2018
Q3 2018 19% +13% +217% 01 Jul 2018 30 Sep 2018
Q2 2018 23% +31% 01 Apr 2018 30 Jun 2018
Q1 2018 16% +21% 01 Jan 2018 31 Mar 2018
Q4 2017 11% +15% 01 Oct 2017 31 Dec 2017
Q3 2017 6.1% -1.6% -21% 01 Jul 2017 30 Sep 2017
Q2 2017 -7.4% -18% -169% 01 Apr 2017 30 Jun 2017
Q1 2017 -4.7% -17% -138% 01 Jan 2017 31 Mar 2017
Q4 2016 -3.4% -28% -114% 01 Oct 2016 31 Dec 2016
Q3 2016 7.7% -26% -77% 01 Jul 2016 30 Sep 2016
Q2 2016 11% -21% -66% 01 Apr 2016 30 Jun 2016
Q1 2016 13% -47% -79% 01 Jan 2016 31 Mar 2016
Q4 2015 25% -26% -51% 01 Oct 2015 31 Dec 2015
Q3 2015 33% +7.6% +29% 01 Jul 2015 30 Sep 2015
Q2 2015 32% +3.6% +13% 01 Apr 2015 30 Jun 2015
Q1 2015 60% +76% 01 Jan 2015 31 Mar 2015
Q4 2014 51% +66% 01 Oct 2014 31 Dec 2014
Q3 2014 26% 01 Jul 2014 30 Sep 2014
Q2 2014 28% 01 Apr 2014 30 Jun 2014
Q1 2014 -17% 01 Jan 2014 31 Mar 2014
Q4 2013 -15% 01 Oct 2013 31 Dec 2013

ENANTA PHARMACEUTICALS INC Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2025 -26% +2.6% +8.9% 01 Oct 2024 30 Sep 2025
2024 -29% +4.1% +13% 01 Oct 2023 30 Sep 2024
2023 -33% -2.5% -8.3% 01 Oct 2022 30 Sep 2023
2022 -30% -13% -76% 30 Sep 2021 30 Sep 2022
2021 -17% -10% -140% 01 Oct 2020 30 Sep 2021
2020 -7.2% -17% -172% 01 Oct 2019 30 Sep 2020
2019 9.9% -9.5% -49% 01 Oct 2018 30 Sep 2019
2018 19% +13% +217% 01 Oct 2017 30 Sep 2018
2017 6.1% -1.6% -21% 01 Oct 2016 30 Sep 2017
2016 7.7% -26% -77% 01 Oct 2015 30 Sep 2016
2015 33% +7.6% +29% 01 Oct 2014 30 Sep 2015
2014 26% 01 Oct 2013 30 Sep 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.